Advertisement
Advertisement

NMRA

NMRA logo

Neumora Therapeutics, Inc. Common Stock

1.74
USD
Sponsored
0.00
-0.23%
Jun 04, 13:46 UTC -4
Open

NMRA Earnings Reports

Positive Surprise Ratio

NMRA beat 6 of 11 last estimates.

55%

Next Report

Date of Next Report
Aug 03, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/
-$0.24
Implied change from Q1 26 (Revenue/ EPS)
--
/
-20.00%
Implied change from Q2 25 (Revenue/ EPS)
--
/
-27.27%

Neumora Therapeutics, Inc. Common Stock earnings per share and revenue

On May 07, 2026, NMRA reported earnings of -0.30 USD per share (EPS) for Q1 26, beating the estimate of -0.31 USD, resulting in a 5.12% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -16.74% price change (close before vs. close after earnings).
Looking ahead to Q2 26, -- analysts forecast an EPS of -0.24 USD, with revenue projected to reach -- USD, implying an decrease of -20.00% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Greenwich LifeSciences, Inc.
Report Date
Jun 01, 2026 For Q4 25
Estimate
-$0.32
Actual
-$0.57
Surprise
-77.70%
logo
Connect Biopharma Holdings Limited Ordinary Shares
Report Date
May 22, 2026 For Q1 26
Estimate
-$1.53
Actual
-$2.35
Surprise
-53.05%
FAQ
For Q1 2026, Neumora Therapeutics, Inc. Common Stock reported EPS of -$0.30, beating estimates by 5.12%, and revenue of $0.00, 0% as expectations.
The stock price moved down -16.74%, changed from $2.33 before the earnings release to $1.94 the day after.
The next earning report is scheduled for Aug 03, 2026.
Based on -- analysts, Neumora Therapeutics, Inc. Common Stock is expected to report EPS of -$0.24 and revenue of -- for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement